GLIMET DS (Glipizide (5mg) + Metformin (500mg))

Glimet DS Tablet is classified as an anti-diabetic medication, specifically formulated to assist in managing type 2 diabetes in adults. This pharmaceutical is a combination of two active ingredients that work together to help regulate blood glucose levels in individuals diagnosed with diabetes. It is essential to take Glimet DS Tablet alongside food to enhance its efficacy and minimize potential gastrointestinal side effects. Consistency in administration—taking the tablet at the same time each day—is crucial for optimal results. The treating physician will determine the appropriate dosage tailored to individual needs, which may vary depending on the patient’s blood sugar monitoring. Continuation of this medication is important, even if patients feel well or experience stable blood sugar levels. Discontinuing the drug without medical guidance could lead to significantly elevated blood sugar levels, raising the risk of serious complications like kidney damage, vision impairment, nerve issues, and possibly amputation. It is important to understand that the medication is part of a comprehensive diabetes management program that should also integrate a balanced diet, regular physical activity, and weight management as per the healthcare provider’s recommendations. Lifestyle adjustments play a pivotal role in achieving effective diabetes control. One of the principal side effects associated with Glimet DS Tablet is hypoglycemia, or low blood sugar. Recognizing symptoms such as sweating, dizziness, and tremors is vital, and it is advisable to maintain a consistent meal schedule and have quick sources of glucose available to counteract potential hypoglycemic events. Other possible side effects include changes in taste, nausea, diarrhea, abdominal discomfort, headaches, swelling, blurred vision, increased risk of bone fractures, and upper respiratory infections. Weight gain may also occur in some individuals using this medication. Importantly, Glimet DS Tablet is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver dysfunction. Prior to initiating treatment, patients should inform their healthcare provider about any history of heart disease. Regular monitoring of blood glucose levels is necessary, and healthcare providers may also recommend laboratory tests to track blood cell counts and liver health.